| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-01-22 | cariprazine | adult schizophrenia patients with persistent and predominant negative symptoms | 3b | Gedeon Richter (Hungary) Actavis (Ireland) | CNS diseases - Mental diseases |
| 2015-01-22 | Lupuzor™ (rigerimod) | systemic lupus erythematosus |
3 | ImmuPharma (UK) | Autoimmune diseases |
| 2015-01-22 | masitinib in combination with gemcitabine or carboplatin or capecitabine | breast cancer | 2 | AB Science (France) | Cancer - Oncology |
| 2015-01-21 | ML7 | eye surface diseases, particularly dry eye |
preclinical | Neuroptis Biotech (France) | Ophtalmological diseases |
| 2015-01-21 | Nefecon® | primary IgA nephropathy |
1 | Pharmalink (Sweden) | Renal diseases - Rare diseases - Kidney diseases |
| 2015-01-21 | EXPEC vaccine | infections caused by Extra-intestinal Pathogenic Escherichia coli (ExPEC), such as urinary tract infections (UTIs) |
1 | GlycoVaxyn (Switzerland) Janssen Pharmaceutical, a J&J Company (USA) | Infectious diseases |
| 2015-01-20 | BI-1206 | chronic lymphocytic leukaemia (CLL), non-Hodgkin lymphoma (NHL) | 1-2 | BioInvent International (Sweden) Cancer Research UK (UK) Cancer Research Technology (CRT) (UK) Leukaemia & Lymphoma Research (UK) | Cancer - Oncology |
| 2015-01-20 | asfotase alfa | hypophosphatasia | Alexion Pharmaceuticals (USA - CT) | Rare diseases - Genetic diseases - Metabolic diseases | |
| 2015-01-20 | LMTX™ (leuco-methylthioninium) Tau Aggregation Inhibitor | Alzheimer's disease |
2 | TauRx Therapeutics (Singapore - UK) | Neurodegenerative diseases |
| 2015-01-20 | NuQ® assays | ovarian cancer |
VolitionRx (Singapore) Singapore General Hospital (Singapore) | Cancer - Oncology | |
| 2015-01-20 | VS-5584 in combination with VS-6063 | mesothelioma |
1 | Verastem (USA - CA) | Cancer - Oncology |
| 2015-01-19 | inecalcitol | chronic myeloid leukemia (CML) | 2 | Hybrigenics (France) | Cancer - Oncology |
| 2015-01-19 | SAR156597 | idiopathic pulmonary fibrosis | 2 | Sanofi (France) | Lung diseases - Respiratory diseases - Rare diseases |
| 2015-01-16 | VS-5584 | preclinical | Verastem (USA - CA) | Cancer - Oncology | |
| 2015-01-15 | NW-3509 | schizophrenia |
1 | Newron Pharmaceuticals (Italy) | Mental diseases - CNS diseases |
| 2015-01-14 | SRP-4053 | Duchenne Muscular Dystrophy | 1-2 | Sarepta Therapeutics (USA - MA) Institut de Myologie (France) Consultants for Research in Imaging and Spectroscopy, Great Ormond Street Hospital for Children (UK) NHS Foundation Trust (UK) Catholic University of the Sacred Heart (UK) Royal Holloway University (UK) SYSNAV, University College, London (UK) University of Newcastle Upon-Tyne (UK) | Rare diseases - Genetic diseases - Neuromuscular diseases |
| 2015-01-13 | PM1183 (lurbinectidin) in combination with doxorubicin | small cell lung cancer |
3 | PharmaMar (Spain) | Cancer - Oncology |
| 2015-01-13 | taselisib | breast cancer | 3 | Roche (Switzerland) | Cancer - Oncology |
| 2015-01-12 | SAGE-547 | postpartum depression | 2a | Sage Therapeutics (USA - MA) | CNS diseases - Mental diseases - Women health |
| 2015-01-12 | Tumor Treating Fields (TTFields) together with gemcitabine | newly-diagnosed advanced pancreatic adenocarcinoma |
2 | Novocure (UK) | Cancer - Oncology |
